Modern Drug Discovery ACS Publications
  From Concept to Development
About MDD - Subscription Info
Article Indexes
Author Indexes

Author Index Article Index
2003 2003
2002 2002
2001 2001
2000 2000

2000 Author Index

Andrews-Cramer, Kathe. Compound collections get focused. Jan./Feb., p. 55.

Ansell, John. The dynamics of genomics deals. Sept., p. 69.

Arrowsmith, Cheryl H. Proteomics: New tools for a new era. Sept., p. 34.

Ashwanden, Christie. Chasing a cure for the common cold. July/Aug., p. 47.

Atter, Glenn. “Superindex” developed to access legacy data. April, p. 65.

Baeuerle, Patrick A. Nanoscalpels: Immunotherapy for cancer. April, p. 37.

Baker, Oliver. Unlocking the blood–brain barrier. April, p. 15. A ribozyme with discretion. May, p. 12. Something to chew on. June, p. 10. RNA virologists fell “The Big One”. July/Aug., p. 11.

Beckman, Mary. Dealing with diabetes. Jan./Feb., p. 23.

Besterman, Jeffrey M. Targeting gene regulators for cancer therapy. April, p. 51.

Borchardt, John K. Playing the economics game with outsourcing. March, p. 28. Shielding against flu epidemics. Nov./Dec., p. 57.

Boring, Dan. Names, names, names. Sept., p. 31. More names. Oct., p. 35.

Bradley, David. Tightening the obesity–bone linchpin. May, p. 11. Mucosal protection and HIV. May, p. 15. A chamber for hemophiliacs. June, p. 9. Sperm and eggs. June, p. 14. A new piece to the MS puzzle. June, p. 16. Suicide linked to 5-HT gene fault. July/Aug., p. 15. Bringing the PXE gene to light. Sept., p. 12. Plasmin: A factor in Alzheimer’s? Sept., p. 16. Seizing the opportunity. Nov./Dec., p. 13. Brain booster surprise. Nov./Dec., p. 18.

Branca, Andrew. The dynamics of genomics deals. Sept., p. 69.

Brem, Rachel. Protein microarrays. May, p. 87.

Brignole, Ed. Breakthrough treatment for bone cancer patients. July/Aug., p. 16. Laser capture microdissection. Nov./Dec., p. 64.

Brower, Vicki. Clearing up skin inflammation. April, p. 11.

Burrill, Steven G. When the going gets tough. March, p. 59. The beginning of the Biotech Century? May, p. 75.

Chao, David. A strategic framework for partnering. Oct., p. 63.

Charles, Stephen A. Improving hepatitis C therapy. Sept., p. 59.

Cole, Clayton J. Permeability assays. Oct., p. 73.

Collins-Gold, Lynn. Are lipid emulsions the drug delivery solution? April, p. 44.

Demidov, Vadim. Peptide Nucleic Acids: Protocols and Application (book review). July/Aug., p. 83.

des Pallieres, Bertrand. Proteomics: New tools for a new era. Sept., p. 34.

Dickson, Michael C. Choosing a discovery framework. April, p. 77.

Eberhardt, Werner. On the cutting edge: Lab on a chip. March, p. 63.

Edwards, Aled M. Proteomics: New tools for a new era. Sept., p. 34.

Evenson, Jeffrey. A strategic framework for partnering. Oct., p. 63.

Felton, Michael J. Breathing in the brain. July/Aug., p. 11. Glass delivery. Sept., p. 16. The pharmaceutical job market keeps growing and glowing. Oct., p. 39. Cooperative toxicology. Oct., p. 81. Survival of the fittest in drug design. Nov./Dec., p. 48.

Feichtinger, Norbert. Are lipid emulsions the drug delivery solution? April, p. 44.

Frost, Randall. Hormones and cognition. Nov./Dec., p. 14.

Gal, Jonathan. Biostartups are fertile ground for entrepreneurs. April, p. 61.

German, Joel B. Of mice and men. June, p. 63. Of mice and men (part II). July/Aug., p. 67.

Goto, Natalie. Gambling with food safety. Sept., p. 25.

Grammer, Susan. New genes restore “heart” to failing hearts. April, p. 12. Curtailing colorectal cancer. May, p. 25.

Guterman, Lila. Speeding molecular origami. Jan./Feb., p. 14. A salty kiss of death. March, p. 84. Intolerant mice provide clue to multiple sclerosis. April, p. 15.

Harris, J. Milton. Improving hepatitis C therapy. Sept., p. 59.

Hart, Carol. Monitoring medications in the marketplace. June, p. 40.

Helmuth, Laura. Heart disease mutations teased out. March, p. 11. Sleep: Get it or regret it. April, p. 21. Skin cells zip into place. May, p. 11. Buzzing about potential antimalarials. June, p. 13.

Herklots, Hans. Outsourcing the search for leads. March, p. 46.

Hodgkin, Edward. Compound collections get focused. Jan./Feb., p. 55.

Hodnett, Daniel L. Choosing a discovery framework. April, p. 77.

Holliman, Leela. Analog-ous research. Oct., p. 17. Mad protein structures. Oct., p. 18. Going for fold in Asilomar. Nov./Dec., p. 40. G-proteins and platelets. Nov./Dec., p. 18.

Johnston, Nicole. The ethics of gene therapy. May, p. 21. Overcoming hypoxia. June, p. 13. Agriculture and antibiotics. Sept., p. 21. Psoriasis drug inhibits nicotine metabolism. Nov./Dec., p. 27.

Johnston, Nicole. Ferreting out the flu. Jan./Feb., p. 9. Optically tracking cells. March, p. 11. Stem cells for diabetes. March, p. 19. Self-regenerating antibodies. April, p. 11. Gene therapy trials. June, p. 25. Delivering the genes. July/Aug., p. 15. Wound healing in diabetic mice. Sept., p. 12. Metalloproteinase inhibitor design. Oct., p. 11. Psoriasis drug inhibits nicotine metabolism. Nov./Dec., p. 27.

Josephson, Julian. Tapping traditional healers’ treasures. May, p. 45. Battling joint destruction. June, p. 10.

Kaufman, George B. Lithium and depression. Jan./Feb., p. 71. Pharmaceutical Innovation: Revolutionizing Human Health (book review). Oct., p. 85.

Keller, Jerry. Pharmaceuticals and the GMO scare. May, p. 35.

King, Vanessa. A strategic framework for partnering. Oct., p. 63.

Kling, Jim. The trouble with training. Jan./Feb., p. 19. Blocking HIV’s “scissors”. March, p. 37. Educating adult stem cells. June, p. 16. Redeeming thalidomide. June, p. 35. Reducing pain with self-hypnosis. July/Aug., p. 19. ABO-incompatible kidney transplants. July/Aug., p. 19. Eotaxin and food allergies. Sept., p. 15. Dynamic pharmacophore for integrase. Sept., p. 15. Calcium-activated channel changer. Oct., p. 12. Bound to be trouble. Oct., p. 18. The strange case of Premarin. Oct., p. 47. High- affinity bonus. Nov./Dec., p. 14. Heparin syntheses. Nov./Dec., p. 20.

Knapman, Katriona. Polymorphic predictions. March, p. 53. Resources for drug development. June, p. 75.

Kniaz, David. Drug discovery adopts factory model. May, p. 67.

Koehler, Christopher S. W. Benjamin Rush and heroic medicine. April, p. 71. How thalidomide was kept out of the U.S. market. June, p. 69. Bring out your dead! Nov./Dec., p. 75.

Kramer, Bruce. What is nonobviousness? Sept., p. 73.

Kuklin, Alexander. Spot checks. May, p. 52.

Kumar, Saran. Improving hepatitis C therapy. Sept., p. 59.

Ladd, Bill. Intuitive data analysis: The next generation. Jan./Feb., p. 46.

Larson-Irwin, Donna. Bioconjugate chemistry. Sept., p. 79.

Ledbetter, Erik. Real estate: The REIT way to invest. Jan./Feb., p. 64. Cornerstone of an industry. April, p. 25. Cornerstone of an industry (part II). May, p. 81.

Leslie, Mitchell. Gene therapy in thalassemic mice. Oct., p. 11.

Lesney, Mark S. A seminal idea. Jan./Feb., p. 9. Time to Heal: American Medical Education from the Turn of the Century to the Era of Managed Care (book review). Jan./Feb., p. 79. Following the fragile. March, p. 15. Biological solvent for killing tumors. March, p. 16. Central Nervous System Diseases: Innovative Animal Models from Lab to Clinic (book review). March, p. 77. Genomics: The Science and Technology Behind the Human Genome Project (book review). April, p. 81. Pills-A-Go-Go: A Fiendish Investigation into Pill Marketing, Art, History & Consumption (book review). April, p. 81. Barnyard biotech. May, p. 57. Scandals and scalawags. May, p. 91. DNA Vaccines: Methods and Protocols (book review). June, p. 79. The Monk in the Garden: The Lost and Found Genius of Gregor Mendel, the Father of Genetics (book review). Sept., p. 95. What about the FDA? Oct., p. 29. Genetic Transportation. Oct., p. 55. Drug Targeting: Strategies, Principles and Applications (book review). Oct., p. 85. An epidemic of osteoporosis? Oct., p. 96. A New Broom? Nov./Dec., p. 31. A plague on all our houses? Nov./Dec., p. 96.

Leytes, Lev. J. High-throughput genomics. May, p. 40.

Littlehales, Crispin. Paying for “lifestyle drugs”. June, p. 47.

Mack, John. Pharmaceutical uses of the Internet. May, p. 97.

MacLeod, A. Robert. Targeting gene regulators for cancer therapy. April, p. 51.

MacNeil, John. Bubble jet biochip bonanza. July/Aug., p. 71. Expanding biosynthetic pathways. Oct., p. 12.

Martell, Patrick. Software supports “the scientific conversation”. Jan./Feb., p. 68.

McCague, Ray. Building chirality from the ground up. July/Aug., p. 28.

McDowell, Julie. Shop at your own risk. Jan./Feb., p. 10. Cosmic radiation and pilots. March, p. 12. Linking learning disabilities to schizophrenia. March, p. 12. Therapy with rhythm. May, p. 19. Flu: The Story of the Great Influenza Pandemic of 1918 (book review). May, p. 105. The Dress Lodger (book review). June, p. 79. The cost of causing pain to animals. July/Aug., p. 12. USP reviews saw palmetto effectiveness. Sept., p. 19. The corpus and the hare. Oct., p. 77. Betrayal of Trust (book review). Nov./Dec., p. 79.

Miller, Dickinson J. Is it time to switch to bonds? June, p. 59. Don’t let errors deflate your pension. Nov./Dec., p. 65.

Miller, Jennifer B. Liver replacements. Jan./Feb., p. 10. The importance of being “dotcom”. Jan./Feb., p. 75. Using Antibodies, A Laboratory Manual (book review). Jan./Feb., p. 79. Malaria: Life cycle of a killer. Jan./Feb., p. 88. Breaching the blood–brain barrier. March, p. 16. The microhighway. March, p. 16. Guineapigs dot-com. March, p. 73. A Brief History of Drugs: From the Stone Age to the Stoned Age (book review). March, p. 77. Hormonal therapy for treating breast cancer. April, p. 16. Finding leads fast and cheap by bioinformatics. April, p. 19. Tangled webs and sticky plaques. April, p. 88. A delicate balance of iron. May, p. 128. B2B marketplace for scientists. June, p. 9. The postgenome era. June, p. 14. The torment of bipolarity. June, p. 88. Vying for vision. July/Aug., p. 16. Conduct Unbecoming a Woman (book review). July/Aug., p. 83. I can’t hear you. July/Aug., p. 96. The bane of Crohn’s disease. Sept., p. 112.

Moore, Jeff. “Superindex” developed to access legacy data. April, p. 65. Silence maims. June, p. 19.

Morin, Amy. Mapping TB’s response to drugs. Jan./Feb., p. 13. Predicting epileptic seizures. March, p. 15. SCA1 dressed in many genes. May, p. 16.

Mort, Mona. Bioinformatics battles breast cancer. Jan./Feb., p. 28. Multiple modes of drug delivery. April, p. 30. Spicing up inflammation. May, p. 15.

Neubert, Hanns-J. Fraud in the German healthcare system. July/Aug., p. 21.

Pal, Kollol. The keys to chemical genomics. Sept., p. 46.

Pedder, Simon. Improving hepatitis C therapy. Sept., p. 59.

Peet, Norton P. Rational drug design. March, p. 21. Drug discovery technology: A preview. June, p. 55.

Pfund, William P. Permeability assays. Oct., p. 73.

Pizzi, Richard A. Defying diabetes: The discovery of insulin. July/Aug., p. 77. Learning our ABC’s (and Ds and Ks). Sept., p. 83. Black Stork (book review). Nov./Dec., p. 79.

Razvi, Enal S. High-throughput genomics. May, p. 40.

Roberts, Shauna S. Take two: Aspirin. Oct., p. 23.

Ryan, James. Stalwart support. Jan./Feb., p. 7. The postindividual age. March, p. 7. Delivering the goods. April, p. 7. Opportunity and information. May, p. 7. First, do no harm. June, p. 7. Confidence. July/Aug., p. 7. The Pharmaceutical Century. Sept., p. 7. Genomic job security. Oct. p. 7. Molecular modeling. Nov./Dec., p. 7.

Scheindlin, Stanley. The discoverer of Aureomycin. March, p. 67.

Schmidt, Charles W. Policing Internet pharmacies. July/Aug., p. 25. Patient health information goes electronic. Nov./Dec., p. 35.

Schrope, Mark. Hot flash: Gabapentin. Sept., p. 11. Stem-cell survival. Nov./Dec., p. 13. An insulin replacement? Nov./Dec., p. 20.

Sleep, Nicolas. Sorting out combinatorial chaos. July/Aug., p. 36.

Smith, Peter M. “Superindex” developed to access legacy data. April, p. 65.

Smith, Wilder. The cow cure. Jan./Feb., p. 13. Cortisol and childhood bullies. May, p. 19. Partially stocked shelves at pharmacies. Sept., p. 19.

Strauss, Evelyn. Are drugs for sepsis the “impossible dream”? Jan./Feb., p. 37.

Tasker, Shiv. Web-based clinical trials. Sept., p. 89.

Thomas, Robert J. Early detection of cervical cancer. July/Aug., p. 57.

Vogelson, Cullen T. PEG-ing the microsphere. Nov./Dec., p. 17.

Wärnheim, Torbjörn. Are lipid emulsions the drug delivery solution? April, p. 44.

Willis, Felicia. Breast cancer and lymph nodes. April, p. 12. Making scents of pleasing aromas. April, p. 19. The Anti-Depressant Era (book review). May, p. 105. Triglyceride conundrum. Oct., p. 17.

Willis, Randall. The coxsackie kicker. Sept., p. 11. A step to freedom from smoking? Oct., p. 21. Predicting asthma drug response. Nov./Dec., p. 17.

Wolf, Evelyn. Nanoscalpels: Immunotherapy for cancer. April, p. 37.

Wong, Kathleen. Phase IV: When and why. June, p. 28. Should the eyes have it? March, p. 25. Tissue debates. Nov./Dec., p. 23.

Wright, Eric G. Disclosure: The price of patent protection. Oct., p. 69.

Wrotnowski, Cort. Of Legos and pharmaceuticals. Jan./Feb., p. 14.

Zaitlen, Richard. Of mice and men. June, p. 63. Of mice and men (part II). July/Aug., p. 67.